Updates in Assisted Advanced Technology for Microvascular Free Tissue Transfer in Head and Neck Surgery.

Microvascular free tissue transfer in head and neck surgery has evolved through technological advancements, focusing on enhancing surgical outcomes and reducing complications. The strategic process involves preoperative planning for perforator mapping, intraoperative devices for microvascular anastomoses and patient positioning, and innovative postoperative monitoring techniques ensuring flap viability. This workflow has led to a high flap success rate, although revision surgery can still be necessary.

Examining timing of periorbital interventions in patients with upper division facial paralysis.

Background: Facial paralysis is a life-altering condition that may arise from various etiologies, ranging from trauma to malignancy. Permanent facial paralysis may occur secondary to facial nerve sacrifice or irreversible damage to the nerve. In these particularly devastating cases, protection and maintaining function of the eye is paramount.

Prognostic significance of time trends in treatment of head and neck squamous cell carcinoma.

Purpose: To analyze the impact of demographic, clinical, and management variables on time to treatment initiation (TTI) and overall survival (OS).

Study Design: Retrospective chart review.

Materials And Methods: Medical records of patients diagnosed with head and neck cancer from 2018 to 2020 were reviewed.

Immediate resection of positive margins improves local control in oral tongue cancer.

Objectives: This study investigates the impact of immediate resection of positive margins on local control of oral tongue cancer.

Materials And Methods: We analyzed 273 consecutive oral tongue cancers resected from 2013 to 2018. Additional resection was performed in cases during the initial operation based on surgeon inspection of the specimen and/or frozen margins.

Incidence and medical complications of COVID-19 in the total laryngectomy population: A population-based study.

Objectives: Laryngeal and hypopharyngeal cancers treated with total laryngectomy (TL) may provide a unique avenue for COVID-19 to infect cancer patients. The objective of this investigation was to identify incidence of COVID-19 infection and potential complications in TL patients.

Materials And Methods: Data was extracted from TriNetX COVID-19 research network from from 2019 to 2021 and ICD-10 codes were utilized to query for laryngeal or hypopharyngeal cancer, and outcomes of interest.